Xalud Therapeutics, Inc.
BioTech/Drugs - New York, NY, US
Xalud Therapeutics, Inc. Employees
Xalud Therapeutics, Inc. Senior Management
Xalud Therapeutics, Inc. Details
Xalud Therapeutics is a biotechnology company developing a non-viral gene therapy platform to treat pathologic inflammation through immune modulation. The company is harnessing the power of interleukin-10 (IL-10), a potent cytokine that acts as a master regulator for multiple inflammatory pathways, to address the root cause of inflammation and subsequently restore homeostasis in the immune system. Xalud's lead product candidate, XT-150, is a locally injectable plasmid DNA gene therapy expressing IL-10 to addresses pathologic inflammation and pain.
Website:
xaludthera.com
Employees:
20 - 49
HQ:
212-301-6673
Location:
New York, NY, US
Revenue:
2.5 - 5 Million
Xalud Therapeutics, Inc. Technologies
Email Providers
Outlook
Load Balancers
Varnish
CMS
Wix
Other
Mobile Friendly
Hosting
Google Cloud Hosting